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Background: Five of 7 (71%) elderly immunocompetent patients with cytomegalovirus retinitis had retinal arteriolar
occlusions versus 2 of 8 (25%) elderly immunocompromised patients and 1 of 19 (5%) younger HIV-infected
patients. Compared to HIV-infected patients, elderly patients were more likely to have occlusive events,
neovascularization or hemorrhage, and underlying vasculopathy. The purpose of this study is to report the novel
finding of extensive retinal arteriolar occlusions and neovascularization in immunocompetent patients with
cytomegalovirus retinitis. This is a retrospective observational cohort study of cytomegalovirus retinitis (CMVR) in
a university setting. Seven patients were elderly but not immunocompromised, 8 were elderly and iatrogenically
immunocompromised, and 16 were HIV-infected. All patients underwent polymerase chain reaction testing of
intraocular fluid. Primary outcome measure was visual acuity. Secondary outcome measures were vascular
occlusions, ischemic complications, and response to treatment.
Results: Mean age was 73, 70, and 41 years for immunocompetent, immunocompromised, and HIV-infected patients,
respectively. Diabetes and vascular disease were common in the elderly. Vision loss to less than 5/200 occurred in 50%
of the immunocompetent elderly patients, and 17% of CMV eyes in immunocompromised and HIV patients. Occlusion
of the entire retinal vasculature occurred in 4/7 (57%) of immunocompetent patients despite lack of Zone I
involvement, and rubeosis occurred in three, disc neovascularization in one, and vitreous hemorrhage in two patients.
Vascular occlusive events were less common in immunocompromised patients and rare in the HIV-infected.
Conclusions: CMVR in non-HIV-infected elderly patients is associated with retinal arteriolar occlusions. An intact host
immune response may increase damage to retinal vessels. Prompt diagnosis may avert catastrophic vision loss.
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Cytomegaloviral infection is common. Seroprevalence
increases steadily in the USA from 36.3% in 6 to
11-year-olds to 90.8% of those aged 90 or older [1]. The
most common ocular manifestation of cytomegalovirus
infection is cytomegalovirus retinitis (CMVR), which
typically occurs as a resurgent infection in a latently
infected host who is severely immunocompromised by
HIV infection, chemotherapy, or organ transplantation.
CMVR can also rarely present in the elderly or in other
minimally compromised individuals as an atypical acute* Correspondence: jdavis@med.miami.edu
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in any medium, provided the original work is pretinal necrosis (ARN) [2-4]. Recognition of cytomegalo-
virus infection is important as specific anti-CMV treat-
ments rather than the anti-viral agents used for other
herpes class viruses are required to control the infection.
We present cases of CMVR in 15 elderly, non-
HIV-infected adults in order to facilitate clinical recogni-
tion and to expand the current literature. Eight of the 19
affected eyes had devastating visual outcomes after
delays in diagnosis; in 5 of the 8 eyes, this was due
to retinal arteriolar occlusion, a previously under-
recognized complication of CMVR. The frequency of
retinal vascular occlusion was much higher than in
younger HIV-infected patients with CMVR.Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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Fifteen patients age 60 and older were identified who
were not HIV-infected and had a diagnosis of CMVR
after diagnostic PCR testing. Seven, with an average age
of 73 ± 7.4 years, were judged to be immunocompetent.
Of these, one was taking low doses of oral corticoste-
roids for healed giant cell arteritis, and four had con-
trolled diabetes mellitus; one had chronic lymphocytic
leukemia (CLL) that was controlled with no medication
(Table 1). Eight patients, with an average of 72.2 ± 12.2
years, were judged to be immunocompromised. Of these,
two were organ transplant recipients, and two had
lymphoma being treated with chemotherapy; the
remaining patients were receiving immunosuppression
for a variety of autoimmune disorders (Table 2). Sixteen
HIV-infected patients with CMVR were selected for
comparison because the diagnosis had been confirmed
with PCR, and they were contemporaneous (2000–2005)
with the non-HIV-infected patients. Average age was
40.3 ± 11.6 years.
Males accounted for approximately 70% of the patients
in each group (P = 0.56). None of the immunocompe-
tent patients had bilateral disease (0%), but 4 of the 8
(50%) immunocompromised non-HIV-patients had bila-
teral disease, as well as 4 of the 16 (25%) HIV-infected
patients (P = 0.6). Profound, permanent vision loss
worse than 20/400 occurred in 8 of the 19 eyes in the
elderly, and 10 of the 20 eyes in the HIV-infected
(P = 0.14). In the eight cases of profound vision loss in
the elderly, five were due to arteriolar occlusion, two to
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vision loss was attributable to arteriolar occlusion in
only one case (P < 0.001). The remaining vision loss was
due to retinal detachment or to CMVR.
More arteriolar occlusions occurred in the eyes of the
elderly, immunocompetent patients than in those of
elderly, immunocompromised patients (5 of 7 (71%) vs.
1 of 12 eyes (8%)), P = 0.07. When arteriolar occlusions
in non-HIV-infected patients were compared to HIV-
infected, the results were highly statistically significant
(6 of 19 eyes (32%) vs. 1 of 20 eyes (5%)), P < .001. Fin-
dings associated with ocular ischemia, such as neovascu-
larization, rubeosis, and vitreous hemorrhage, were also
more common in non-HIV-infected patients (6 of 19
eyes (32%) vs. 4 of 20 eyes (20%)), P < 0.003.
Vasculopathic diagnoses such as cardiovascular disease
and diabetes were more common in the elderly, espe-
cially those who were not considered to be otherwise
immunocompromised (Tables 1 and 2). Compared to
HIV-infected patients, vasculopathy was present in 10 of
the 15 patients (67%) vs. 1 of 20 (5%), P < 0.001. Retinal
detachment was more common in eyes in HIV-infected
patients than in non-HIV-infected patients (7 vs. 2,
P = 0.03). Table 3 lists the medical and surgical interven-
tions, and visual and anatomic outcomes.
Case reports
Case 1
A 71-year-old Indian man with hypertension and dia-
betes had blurred vision in the right eye for 3 months.
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cotton-wool spots were noted and there was peripheral
nonperfusion with scattered intraretinal hemorrhages
temporally in the right eye. Diabetic retinopathy was not
present. The left eye was normal.
Fluorescein angiography at that time showed intact
choroidal filling and delayed filling of the arteriolar vas-
culature in the right eye with incomplete filling in the
midperiphery. Subtenon triamcinolone injection was
given elsewhere to treat the inflammation. Toxoplasmo-
sis IgM and IgG antibodies, hepatitis B and C antibodies,
serum immunoelectrophoresis, antidouble-stranded DNA,
hemoglobin A1C, and antinuclear antibody were negative
or normal. Serum herpes simplex virus (HSV) 1 and 2 IgG
were highly positive.
Two months later on referral, visual acuity in the right
eye was 5/200 with eccentric fixation. There was 3+
anterior chamber cell and 1+ flare with small keratic
precipitates and 3+ vitreous cell with moderate haze.
Intraocular pressure was 19 mmHg. Prominent optic nerve
neovascularization was noted, and arterioles appeared
sclerotic and sheathed. Dispersed intraretinal hemorrhages
and a few cotton wool patches were present in the poste-
rior pole. Repeat FA showed lack of perfusion in the area
of retinal infiltration and extensive closure of the central
retinal vasculature with macular nonperfusion (Figure 1).
Nummular retinal infiltrates were seen in the superonasal
quadrant, extending from the equator to the periphery
(Figure 2).Lab testing including complete blood count (CBC),
anti-neutrophil cytoplasmic antibody (ANCA), rapid
plasma reagin (RPR), fluorescent treponemal antibody,
human T-cell lymphotropic virus-1 antibody, leptospira
antibody, and human immunodeficiency virus (HIV)
antibody were negative or normal. PCR analysis of the
aqueous humor was positive for CMV DNA and nega-
tive for HSV 1 and 2, varicella zoster virus (VZV), and
toxoplasmosis. Intravenous ganciclovir was prescribed
but stopped after 3 weeks by an infectious disease spe-
cialist, who found no other signs of CMV disease.
Three months later, the retinitis remained active. Vision
was bare light perception, and the retinal circulation
appeared more occluded. Diagnostic pars plana vitrectomy
with retinal biopsy, membrane peel, and endolaser, and
C3F8 intraocular gas tamponade was performed. PCR of
vitreous fluid was again positive for CMV DNA and nega-
tive for HSV, VZV, toxoplasmosis, and Epstein-Barr virus.
Retinal biopsy showed cytomegalic inclusion bodies and
CMV by immunohistochemistry (Figure 3). At surgery,
the nummular lesions appeared as multiple, intraretinal,
white snowflake opacities with adhesion to the underlying
RPE. No bleeding occurred during retinal incision. All re-
tinal arteries were sclerotic, with a crystalline appearance,
and the optic nerve head was completely atrophic. On
final follow-up, the patient had a visual acuity of light per-
ception in his right eye with neovascularization of the iris,
ectropion uveae, and dense vitreous hemorrhage despite
endolaser at surgery.
Figure 1 Case 1, posterior fundus, right eye. Left frame: there are sclerotic central vessels and cotton-wool spots located inferotemporal to
the optic disc and fovea. Hemorrhages are located along the superior and inferior vascular arcades. Right frame: late-phase fluorescein
angiography shows minimal retrograde filling from the optic nerve circulation of the retinal vasculature with late intraretinal staining around the
optic nerve. There is extensive capillary nonperfusion peripherally.
Table 3 Medical and surgical interventions in elderly, immunocompetent, and elderly immunocompromised
non-HIV-infected patients with cytomegalovirus retinitis
Case Medical treatment Surgical interventions Retinovascular disease
1 Intravenous ganciclovir Diagnostic paracentesis, diagnostic vitrectomy,
retinal biopsy
Disc neovascularization, rubeosis iridis,
ectropion uvea, vitreous hemorrhage
2 Oral valganciclovir, intravitreal foscarnet,
intracameral bevacizumab
Diagnostic paracentesis, PRP Rubeosis iridis
3 Clarithromycin, atovoquone, valacyclovir,
intravenous and oral ganciclovir
Diagnostic vitrectomy, trabeculectomy, diagnostic
paracentesis, glaucoma drainage device
Rubeosis iridis, neovascular glaucoma
4 Prednisone, subtenon triamcinolone,
valacyclovir, ganciclovir drug delivery device
Diagnostic vitrectomy, CE/IOL Vitreous hemorrhage
5 Intravitreal ganciclovir and foscarnet,
valganciclovir
Diagnostic paracentesis None
6 Intravitreal ganciclovir and foscarnet,
intravenous ganciclovir
Diagnostic paracentesis Sclerotic arterioles in Zone I
7 Intravitreal ganciclovir and foscarnet,
valganciclovir
Diagnostic paracentesis, RD repair None
8 Lost to follow-up Prior diagnostic vitrectomy and PRP, diagnostic
paracentesis
Vitreous hemorrhage
9 Intravitreal ganciclovir and foscarnet,
valganciclovir
Diagnostic paracentesis None
10 Valganciclovir Diagnostic paracentesis None
11 Valganciclovir, intravitreal ganciclovir and
foscarnet
Diagnostic paracentesis None
12 Valganciclovir, intravitreal ganciclovir and
foscarnet
Diagnostic paracentesis Vitreous hemorrhage
13 Intravenous ganciclovir Diagnostic paracentesis None
14 Intravenous ganciclovir, intravitreal ganciclovir
and foscarnet
Diagnostic paracentesis RD repair None
15 Intravenous ganciclovir, intravitreal ganciclovir
and foscarnet
Diagnostic paracentesis None
CE/IOL, cataract extraction with intraocular lens implantation; RD, retinal detachment; PRP, panretinal photocoagulation.
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Figure 2 Case 1, superonasal retina, right eye. There are
nummular patches of a granular necrotizing retinitis. A sclerotic
arteriole enters the area. There are scattered intraretinal
hemorrhages proximal to the optic nerve head.
Davis et al. Journal of Ophthalmic Inflammation and Infection 2013, 3:17 Page 5 of 8
http://www.joii-journal.com/content/3/1/17Case 2
An 81-year-old white man experienced decreased vision
and redness in his right eye that worsened over 3 weeks.
Past medical history was significant for multiple sclerosis
in 1950 with bilateral optic neuritis in remission, cere-
brovascular accident in 2000, hyperlipidemia, and dia-
betes. Granulomatous anterior segment inflammation
and a central retinal artery occlusion of the right eye
were noted by an outside ophthalmologist. Serum CMV
IgG antibody and varicella zoster antibody were positive.
CMV IgM antibody, HSV I and II IgG antibodies, and
syphilis antibody were negative. Carotid artery stenosis
was 70% to 80% on the right and 50% on the left on ca-
rotid Doppler ultrasound. Varicella-related necrotizing
retinitis was suspected, and famciclovir 500 mg three
times daily was initiated.
On referral 2 months after onset, vision was counting
fingers at 6 feet in the right eye and 20/20 in the left eye
with a 2+ relative afferent pupillary defect in the rightFigure 3 Case 1, retinal biopsy. Left frame: hematoxylin and eosin stain
(arrows), ×100. Right frame: immunohistochemical stain with anti-cytomeg
stain indicates retinal cells positive for cytomegalovirus antigens. Figures coeye. There were large white keratic precipitates on the
right corneal endothelium, 2+ anterior chamber cell, and
1+ flare. On dilated examination of the right eye, the
optic nerve was pale, with sclerotic, attenuated arter-
ioles, segmentation of the venous blood columns, and
no evidence of recanalization (Figure 4). There was a
patchy, granular retinitis in the inferotemporal quadrant.
The diagnosis of necrotizing retinitis with central retinal
artery occlusion was made. The left eye was free of
inflammation.
Diagnostic AC paracentesis for PCR for CMV, varicella
zoster virus, and herpes simplex virus was positive for
CMV DNA only. HIV serology was negative. An intravi-
treal injection of foscarnet was given and oral valganci-
clovir was started. Three months later, there was florid
neovascularization of the iris. The retinitis was inactive.
Bevacizumab was injected intracamerally, and PRP was
performed with regression of the NVI. Vision remained
stable at hand motions. Valganciclovir was continued at
450 mg daily adjusted for renal function to complete 3
months of treatment.
Case 3
A 66-year-old white man presented with 3 weeks of
blurred vision and floaters in his left eye. Past medical
history was significant for chronic open angle glaucoma
and CLL status post chemotherapy, with last treatment
1.5 years prior. The patient denied pain, redness, or
photophobia. Vision was 20/20- in the right eye and 20/
30 in the left eye. The intraocular pressure was 20
mmHg in the right eye and 26 mmHg in the left eye. Slit
lamp exam showed 2+ flare with rare cells and fine kera-
tic precipitates in the left eye. Fundus examination on
the left revealed 2+ vitreous cells. There was a small
patch of chorioretinitis present in the superotemporal
periphery. A presumptive diagnosis of toxoplasmosis
chorioretinitis was made. Clarithromycin and atovaquone
were started; laboratory studies included complete
blood count with differential, complete metabolic profile,of retinal biopsy specimen showing cytomegalovirus inclusion bodies
alovirus antibody and avidin-biotin-peroxidase complex, 100X. Brown
urtesy of Sander Dubovy, MD.
Figure 4 Case 2, posterior fundus, right eye. Left frame: 5 weeks after vision loss from central retinal artery occlusion, there is no
recanalization of the artery. The venous blood columns are segmented with a few intraretinal hemorrhages. Retinitis is barely visible
inferotemporal to the macula. Right frame: the inferotemporal periphery shows nummular lesions of a granular retinitis similar to Case 1.
The vascular closure is generalized rather than specific to the area of retinitis.
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B27, and angiotensin converting enzyme. CBC was
remarkable with 63,300 WBC with 92.4% lymphocytes. All
other laboratory studies were within normal limits;
HLA-B27 antigen was present. Subsequent toxoplasmosis
IgG was positive, with a negative IgM.
After 1 week, the retinitis appeared to resolve, but one
month later, vision dropped to 20/200. Intraocular pres-
sure was 32 mmHg with 1+ anterior chamber cell and
flare and 2+ vitreous cells. Fundus examination showed
extensive arteriolar closure with segmentation of the
venous circulation confirmed by fluorescein angiography
(Figure 5). The focus of chorioretinitis superotempo-
rally had enlarged slightly (Figure 6, left). Diagnostic vi-
trectomy was performed 2 days later; vision prior to sur-
gery had declined to 6/200 ‘E’. The vitrectomy was
combined with trabeculectomy with mitomycin C. Vitre-
ous fluid was sent for PCR analysis for CMV, HSV 1 and
2, and VZV DNA, as well as toxoplasma IgG, flowFigure 5 Case 3, posterior fundus, left eye. Left frame: the vasculature i
hemorrhages. Right frame: arteries and veins are truncated with extensive ccytometry and cytology, and viral culture. All of these
tests were negative.
Empiric valacyclovir was started. The retinal vessels
appeared attenuated with macular ischemic whitening
consistent with central retinal artery occlusion. Two
weeks later, vision declined to 3/200 ‘E’. Anterior
chamber paracentesis was performed, and CMV DNA
was detected by PCR. Intravenous ganciclovir was
started 300 mg every 12 h for 14 days followed by
oral ganciclovir 1 gram three times daily. Within 2
months, the retinitis appeared healed; however, neo-
vascular glaucoma developed requiring Baerveldt glau-
coma drainage implant. The intraocular inflammation
and retinitis reactivated, with focal nummular white
lesions encroaching on the superior arcade. No
further therapeutic intervention was recommended
due to poor visual prognosis, and the retinitis eventu-
ally progressed to involve most of the periphery
(Figure 6, right).s perfused centrally but there are sheathed arterioles and intraretinal
apillary nonperfusion in the macula.
Figure 6 Case 3, fundus, left eye. Left frame: a single small focus of a granular necrotizing retinitis was present in the superotemporal retina
at the time of central retinal artery occlusion. Right frame: typical CMV retinitis developed several weeks later after discontinuation of systemic
anti-viral therapy with oral ganciclovir.
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The pathogenesis of CMVR likely involves hematogenous
dissemination with initial infection of the vascular endo-
thelium and subsequent spread into adjacent tissues [5].
In HIV infection, breakdown of the blood-retinal barrier
by HIV retinopathy [6] may facilitate viral spread into the
retinal tissue. Pro-inflammatory cytokines may contribute
to the vasculopathic effects of the virus [7] with expression
of endothelial adhesion molecules, leading to increased
platelet and leukocyte adhesion, induction of anti-
phospholipid antibodies, and enhanced factor VIII synthe-
sis and secretion [7].
CMVR and HIV-related branch retinal artery occlu-
sions have been rarely reported [8,9]. There have also
been a few case reports of retinal vascular occlusion
in HIV/AIDS patients without CMVR [10-15]. In the
five cases of ARN-like CMVR in immunocompetent
patients reported in the literature [2,3,16,17], one had
branch retinal artery occlusion [14]. Designation of
patients as immunocompetent or immunocomprom-
ised is imprecise even when special testing of the
immune system is performed. The elderly patients we
deemed immunocompetent were not receiving im-
munosuppression for organ transplantation or chemo-
therapy for cancer, which are the usual causes for
CMVR in non-HIV patients. They were elderly with
associated co-morbidities and, therefore, in a gray
zone of immunocompetency. They represent a large
population at risk for CMVR with few apparent risk
factors other than advanced age.
Well-established risk factors for vascular occlusion
were present in our patients including hypertension,
increased white blood cell counts, uncontrolled glau-
coma, giant cell arteritis, cardiovascular disease, and
carotid stenosis [18]. CMV infection has been associated
with atherosclerosis and with impaired circulation[19,20]. Vascular occlusion contributed to poor visual
acuity outcomes independent of macular involvement or
retinal detachment, which are the usual means by which
patients with CMVR lose vision but were not present in
these patients. A weaker than normal immune system in
these elderly patients that allowed for CMVR combined
with a sufficient immune response to damage and close
vessels moderately impaired by other vasculopathies
may have produced this unique presentation. In cases 1
and 4, the early use of corticosteroids without antiviral
cover before the diagnosis of CMVR was made may have
allowed sufficient worsening to permit this unusual
constellation of findings.
Extensive vascular occlusion occurred when the retinal
surface area involved with retinitis was still quite small.
Although risk factors for vascular closure were present,
the artery occlusions were not typical for embolic dis-
ease, for example, typical cherry-red spots and recanali-
zation did not occur. Despite extensive occlusions as in
cases 1 and 3, at least some portion of the central retinal
circulation remained patent until late in the course. The
process therefore was more likely progressive nonperfu-
sion that finally affected the central vasculature rather
than an acute event such as a central retinal artery oc-
clusion. The incremental closure of the total retinal cir-
culation may have led to other atypical features such as
the high frequency of secondary neovascularization,
which is unusual in central retinal artery occlusion and
also unusual in eyes of patients with CMVR involving
the entire retina.
Conclusion
Retinal artery occlusion can occur in conjunction with
CMVR in elderly, immunocompetent patients. Recogni-
tion of CMV as a rare cause of necrotizing retinitis and
institution of early antiviral treatment may reduce the
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vascular occlusion is an uncommon manifestation of
CMVR, older age, concurrent illnesses, and relatively
intact immune defenses with intravascular inflammation
may have contributed to this devastating outcome.
Methods
Patient lists were searched to identify non-HIV-infected
patients with CMVR from 2000–2007. Medical records
were retrospectively reviewed for age and sex; medical sta-
tus including iatrogenic immunosuppression; ocular char-
acteristics including extent of retinitis, vascular occlusions,
neovascularization, and hemorrhage; clinical estimate of
grade of inflammation; clinical course including timing of
vascular occlusion relative to onset of symptoms; results
of diagnostic studies; medical treatment and response to
medication; surgical interventions; and visual outcomes.
Narrative accounts of three cases considered to be im-
munocompetent who developed retinal arteriolar occlu-
sion were created. Control patients were selected from a
group of HIV-infected patients with CMVR confirmed by
polymerase chain reaction (PCR) testing and previously
reported from this institution [21].
Paired McNemar statistics were used to compare the
presence and absence of bilateral disease, profound vi-
sion loss, arteriolar occlusion, neovascularization or vit-
reous hemorrhage, and retinal detachment between the
non-HIV-infected and HIV-infected patients. Small sam-
ple size hampered comparisons between the elderly,
immunocompromised and elderly, immunocompetent
groups, and the elderly, immunocompetent and HIV-
infected groups. Expedited approval for retrospective
review of medical records was granted by the Human
Subjects Review Board by the University of Miami Miller
School of Medicine with waiver of HIPAA authorization.
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